Research Focus

Compliance and Internal Audit; Lead, Compliance

Recent additions – View all

1. A multicenter phase II study of bortezomib in recurrent or metastatic sarcomas

   Journal Article

   Maki, R. G.; Kraft, A. S.; Scheu, K.; Yamada, J.; Wadler, S.; Antonescu, C. R.; Wright, J. J.; Schwartz, G. K.
   Cancer (2005)

   Fulltext@MSK | Save
2. Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas

   Journal Article

   D'adamo, D. R.; Anderson, S. E.; Albritton, K.; Yamada, J.; Riedel, E.; Scheu, K.; Schwartz, G. K.; Chen, H.; Maki, R. G.
   Journal of Clinical Oncology (2005)

   Fulltext@MSK | Save